Literature DB >> 1137829

Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.

A R Ronald, C K Harding, R Mathias, C K Wong, P Muir.   

Abstract

Twenty-eight females with recurrent urinary tract infection were treated to eradicate their existing infections and then observed for recurrences while receiving one of the three following prophylactic regimens for 6 to 12 months: nitrofurantoin, 50 mg daily; one half tablet of trimethoprim-sulfamethoxazole (TMP-SMX) twice weekly; or one tablet of TMP-SMX once weekly. Preadolescent girls received half the adult doses. After completion of the course of prophylactic agent the patients were followed up at bimonthly intervals until infection recurred. After eradication of this new infection they were started on another prophylactic regimen. Six infections (1.0/patient-year) recurred in patients on nitrofurantoin, four infections (0.4/patients-year) reucrred in those receiving twice weekly TMP-SMX, and 12 infections (1.3/patient-year) in those receiving once weekly TMP-SMX. The mean interval between discontinuation of prophylaxis and recurrence of infection was 2.6 months. TMP-SMX in the doses used eliminated aerobic gram-negative rods from swabs from the anal canal in many patients. Gram-negative organisms resistant to trimethoprim did not cause infection either during or after therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137829      PMCID: PMC1956444     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women.

Authors:  G K Harding; A R Ronald
Journal:  N Engl J Med       Date:  1974-09-19       Impact factor: 91.245

2.  Treatment trials in urinary tract infection (UTI) with special reference to the effect of antimicrobials on the fecal and periurethral flora.

Authors:  J Winberg; T Bergström; K Lincoln; G Lidin-Janson
Journal:  Clin Nephrol       Date:  1973 May-Jun       Impact factor: 0.975

3.  Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.

Authors:  E C Moorhouse; W Farrell
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

4.  Prevention of urinary-tract infection with low-dose nitrofurantoin.

Authors:  R R Bailey; A P Roberts; P E Gower; H E De Wardener
Journal:  Lancet       Date:  1971-11-20       Impact factor: 79.321

5.  Prophylactic long-term cephalexin in recurrent urinary infection.

Authors:  K F Fairley; M Hubbard; J A Whitworth
Journal:  Med J Aust       Date:  1974-03-02       Impact factor: 7.738

6.  The natural history of recurrent bacteriuria in schoolgirls.

Authors:  C M Kunin
Journal:  N Engl J Med       Date:  1970-06-25       Impact factor: 91.245

7.  Long-term treatment of persistent or recurrent urinary tract infection with trimethoprim-sulfamethoxazole.

Authors:  F O'Grady; I K Fry; A McSherry; W R Cattell
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

8.  Recurrent urinary infections in adult women. The role of introital enterobacteria.

Authors:  T A Stamey; M Timothy; M Millar; G Mihara
Journal:  Calif Med       Date:  1971-07

9.  Chronic bacteriuria due to Escherichia coli. II. Correlation of microbiological, and biochemical findings with the clinical results.

Authors:  W Burmfitt; R Pursell; N W Ormonde; J M Murdoch; E Wallace
Journal:  J Infect Dis       Date:  1969-07       Impact factor: 5.226

10.  Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria.

Authors:  M Turck; A R Ronald; R G Petersdorf
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966
View more
  8 in total

1.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

2.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 3.  Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.

Authors:  X Albert; I Huertas; I I Pereiró; J Sanfélix; V Gosalbes; C Perrota
Journal:  Cochrane Database Syst Rev       Date:  2004

4.  Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

Authors:  D A Haase; G K Harding; M J Thomson; J K Kennedy; B A Urias; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

5.  Quinolones and colonization resistance in human volunteers.

Authors:  J J Van Saene; H K Van Saene; J N Geitz; N J Tarko-Smit; C F Lerk
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

6.  Comparative in vitro activity of norfloxacin against urinary tract pathogens.

Authors:  D Haase; B Urias; G Harding; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

7.  Cycloserine as a urinary tract antiseptic.

Authors:  P Kaltenis
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

Review 8.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.